4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-22-016050
Executive Vice President & CFO acquired 36,197 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Konidaris Tasos Executive Vice President & CFO | 2022-03-01 | Option exercise | +36,197 | 123,916 | D | ||
| Derivatives | |||||||
| Konidaris Tasos Executive Vice President & CFO | 2022-03-01 | Option exercise · Restricted Stock Units | −36,197 | 108,591 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2022-03-03 | Grant or award · Restricted Stock Units | +181,159 | 181,159 | D | ||
| Konidaris Tasos Executive Vice President & CFO | 2022-03-03 | Grant or award · Performance-Based Restricted Stock Units | +362,318 | 362,318 | D | ||
Loading xslF345X03/doc4.xml…